RankingsPricing
  1. US-listed companies
  2. Amphastar Pharmaceuticals, Inc.
  3. Financials
  4. Return on Assets

Amphastar Pharmaceuticals, Inc.【AMPH】

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 202410.3-15.41%
Dec 31, 202312.2-5.65%
Dec 31, 202212.9+33.02%
Dec 31, 20219.7+4126.09%
Dec 31, 20200.2-97.41%
Dec 31, 20198.9-847.06%
Dec 31, 2018-1.2-216.67%
Dec 31, 20171-60.47%
Dec 31, 20162.6-458.33%
Dec 31, 2015-0.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)